Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 44 Records) |
Query Trace: Lung Neoplasms and NQO1[original query] |
---|
NQO1, MPO, and the risk of lung cancer: a HuGE review. Genetics in medicine : official journal of the American College of Medical Genetics 2005 Sep 7 (7): 463-78. Kiyohara Chikako, Yoshimasu Kouichi, Takayama Koichi, Nakanishi Yoic |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 May 15 (5): 979-87. Chao Chun, Zhang Zuo-Feng, Berthiller Julien, Boffetta Paolo, Hashibe M |
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007 Jul 18 (7): 1230-42. Vineis P, Veglia F, Garte S, Malaveille C, Matullo G, Dunning A, Peluso M, Airoldi L, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J P, Kaaks R, Boeing H, Trichopoulou A, Palli D, Crosignani P, Tumino R, Panico S, Bueno-De-Mesquita H B, Peeters P H, Lund E, Gonzalez C A, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros J R, Berglund G, Jarvholm B, Day N E, Key T J, Saracci R, Riboli E, Autrup |
Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung cancer (Amsterdam, Netherlands) 2007 Aug 57 (2): 135-42. Yang Mihi, Choi Yunhee, Hwangbo Bin, Lee Jin S |
Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer causes & control : CCC 2009 Mar 20 (2): 137-45. Eom Sang-Yong, Zhang Yan Wei, Kim Sung-Hoon, Choe Kang-Hyeon, Lee Kye Young, Park Jung-Duck, Hong Yun-Chul, Kim Yong-Dae, Kang Jong-Won, Kim He |
Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2009 Jul . Song SY, Jeong SY, Park HJ, Park SI, Kim DK, Kim YH, Shin SS, Lee SW, Ahn SD, Kim JH, Lee JS, Choi EK |
Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 2009 Apr 30 (4): 626-35. Cote Michele L, Yoo Wonsuk, Wenzlaff Angela S, Prysak Geoffrey M, Santer Susan K, Claeys Gina B, Van Dyke Alison L, Land Susan J, Schwartz Ann |
Additional candidates to conventional genes susceptible for lung cancer and changing trend in Japan. Oncology reports 2010 Jun 23 (6): 1493-500. Okazaki Isao, Sugita Minoru, Matsuki Hideaki, Billah Syed Muhammad Baqui, Watanabe Tet |
Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells. Carcinogenesis 2010 Dec 31 (12): 2091-6. Lee Mi-Sun, Su Li, Mark Eugene J, Wain John C, Christiani David |
Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. International journal of cancer 2010 Oct 127 (7): 1547-61. Timofeeva Maria, Kropp Silke, Sauter Wiebke, Beckmann Lars, Rosenberger Albert, Illig Thomas, Jäger Birgit, Mittelstrass Kirstin, Dienemann Hendrik, , Bartsch Helmut, Bickeböller Heike, Chang-Claude Jenny, Risch Angela, Wichmann Heinz-Eri |
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer. Oncology reports 2011 Jun 25 (6): 1765-72. Kolesar Jill M, Dahlberg Suzanne E, Marsh Sharon, McLeod Howard L, Johnson David H, Keller Steven M, Schiller Joan |
Aromatic DNA adducts and number of lung cancer risk alleles in Map-Ta-Phut Industrial Estate workers and nearby residents. Mutagenesis 2013 Jan 28 (1): 57-63. Peluso Marco, Srivatanakul Petcharin, Jedpiyawongse Adisorn, Sangrajrang Suleeporn, Munnia Armelle, Piro Sara, Ceppi Marcello, Boffetta Paolo, Godschalk Roger W L, van Schooten Frederik |
Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PloS one 2012 7 (10): e47939. Guo Shujie, Gao Min, Li Xiaobo, Li Yuqiong, Chu Shaoli, Zhu Dingliang, Niu Wenqu |
Role of NAD(P)H:quinone oxidoreductase polymorphism at codon 187 in susceptibility to lung, laryngeal and oral/pharyngeal cancers. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2013 7 6 (6): 440-7. Benhamou Anu Voho Christine Bouchardy Katja Mitrunen Pierre Dayer Ari Hirvonen |
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec 34 (6): 3967-79. Lou Yuqing, Li Rong, Xiong Liwen, Gu Aiqin, Shi Chunlei, Chu Tianqing, Zhang Xueyan, Gu Ping, Zhong Hua, Wen Shaojun, Han Baoh |
C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin. Clinical Medicine Insights. Oncology 2013 7 31-9. Nagata Misato, Kimura Tatsuo, Suzumura Tomohiro, Kira Yukimi, Nakai Toshiyuki, Umekawa Kanako, Tanaka Hidenori, Matsuura Kuniomi, Mitsuoka Shigeki, Yoshimura Naruo, Oka Takako, Kudoh Shinzoh, Hirata Kazu |
Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. International journal of environmental research and public health 2014 Sep 11 (9): 9491-502. Yilmaz Ahmet, Mohamed Nehad, Patterson Kara A, Tang Yan, Shilo Konstantin, Villalona-Calero Miguel A, Davis Michael E, Zhou Xiaoping, Frankel Wendy, Otterson Gregory A, Beall Howard D, Zhao Weiqia |
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer. International journal of clinical and experimental pathology 2014 7 (10): 6743-51. Kim Ho-Cheol, Song Joon Seon, Lee Jae Cheol, Lee Dae Ho, Kim Sang-We, Lee Jung-Shin, Kim Woo Sung, Rho Jin Kyung, Kim Sun Ye, Choi Chang-M |
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics 2014 15 (12): 1565-74. Lamba Jatinder Kaur, Fridley Brooke L, Ghosh Taraswi M, Yu Qing, Mehta Gaurav, Gupta Pank |
The role of NQO1 polymorphisms in the susceptibility and chemotherapy response of Chinese NSCLC patients. Cell biochemistry and biophysics 2014 Jul 69 (3): 475-9. Tian Gang, Wang Miaomiao, Xu Xiaoga |
Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. Journal of Korean medical science 2015 Mar 30 (3): 221-6. Kim Jin Hee, Hong Yun-Ch |
Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan. Oncology letters 2017 May 13 (5): 3873-3881. Yamamoto Yuzo, Kiyohara Chikako, Suetsugu-Ogata Saiko, Hamada Naoki, Nakanishi Yoic |
NQO1 C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis. Oncotarget 2017 Nov 8 (60): 102301-102309. Huang Jiawen, Lin Huiran, Wu Xiaosong, Jin Weijun, Zhang Zhido |
Evaluation of the risk of lung cancer associated with NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism in male current cigarette smokers from the Eastern India. Molecular biology research communications 2020 12 9 (3): 111-115. Banerjee Santa |
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma. Translational lung cancer research 2021 4 10 (3): 1327-1337. Patiño-García Ana, Guruceaga Elizabeth, Segura Victor, Sánchez Bayona Rodrigo, Andueza Maria Pilar, Tamayo Uria Ibon, Serrano Guillermo, Fusco Juan Pablo, Pajares María José, Gurpide Alfonso, Ocón Marimar, Sanmamed Miguel F, Rodriguez Ruiz Maria, Melero Ignacio, Lozano Maria Dolores, de Andrea Carlos, Pita Guillermo, Gonzalez-Neira Anna, Gonzalez Alvaro, Zulueta Javier J, Montuenga Luis M, Pio Ruben, Perez-Gracia Jose Lu |
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 12 112 (5): 1165-1176. Li Li, Tang Shanshan, Yin Jiani C, Dong Lihua, Yang Zhe, Liu Yueping, Ma Jie, Chang Pengyu, Pang Jiaohui, Bao Hua, Mu Dianbin, Zheng Xiaoli, Aishajiang Reyida, He Kewen, Zhang Shaotong, Ni Meng, Wu Xue, Wang Xiaonan, Shao Yang, Wang Jun, Ge Hong, Yu Jinming, Yuan Shuang |
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer. Frontiers in oncology 2022 12 928605. He Kewen, Zhang Shaotong, Pang Jiaohui, Yin Jiani C, Mu Dianbin, Wang Jun, Ge Hong, Ma Jie, Yang Zhe, Zheng Xiaoli, Dong Lihua, Zhang Junli, Chang Pengyu, Li Li, Tang Shanshan, Bao Hua, Wu Xue, Wang Xiaonan, Shao Yang, Yu Jinming, Yuan Shuang |
Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy. Xenobiotica; the fate of foreign compounds in biological systems 2022 4 52 (3): 322-331. Walia Harleen, Sharma Parul, Singh Navneet, Sharma Siddhar |
Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians. International journal of environmental health research 2022 Oct 1-24. Walia Harleen Kaur, Sharma Parul, Singh Navneet, Sharma Siddhar |
- Page last reviewed:Feb 1, 2024
- Content source: